Homozygous or heterozygous forms of the E4 allele were associated with a higher risk of AD progression through diverse mechanisms, such as reduced amyloid clearance, increased Tau phosphorylation, abnormal mitochondrial function, and abnormal lipid metabolism [15]. Here, MAPT is linked to Alzheimer disease.